A Day Up For DelMar Pharmaceuticals, Inc.
Fri, Nov 22, 2019 at 05:30 PM
DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ) rocketted today at $1.05, representing a gain of 27.4%. On Thu 21 Nov 19, DMPI:NASDAQ hit a New 2-Week High of $0.82. The stock appeared on our News Catalysts scanner on Sun 17 Nov 19 at 12:30 PM. From Fri 01 Nov 19, the stock recorded 57.14% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ)
DelMar Pharmaceuticals Inc is a clinical stage drug development company. It is engaged in research and development of cancer indications.
Top 10 Gainers:
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 293.18%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 54.8%
- Stage Stores, Inc. (SSI:NYSE), 37.46%
- Akerna Corp. (KERN:NASDAQ), 35.33%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 27.66%
- DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ), 27.43%
- Verastem, Inc. (VSTM:NASDAQ), 24.2%
- OpGen, Inc. (OPGN:NASDAQ), 22.12%
- Akebia Therapeutics, Inc. (AKBA:NASDAQ), 21.68%
- The9 Limited (NCTY:NASDAQ), 21.52%